Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    February 2017
  1. NATSUME A, Kato T, Kinjo S, Enomoto A, et al
    Girdin maintains the stemness of glioblastoma stem cells.
    Oncogene. 2017 Feb 20. doi: 10.1038/onc.2017.
    PubMed     Text format    


  2. MASILAMANI AP, Ferrarese R, Kling E, Thudi NK, et al
    KLF6 depletion promotes NF-kappaB signaling in glioblastoma.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    December 2016
  3. VOLPIN F, Casaos J, Sesen J, Mangraviti A, et al
    Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.
    Oncogene. 2016 Dec 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  4. SAREDDY GR, Viswanadhapalli S, Surapaneni P, Suzuki T, et al
    Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  5. GARG N, Bakhshinyan D, Venugopal C, Mahendram S, et al
    CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence.
    Oncogene. 2016 Oct 24. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  6. TALAMILLO A, Grande L, Ruiz-Ontanon P, Velasquez C, et al
    ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  7. HU L, Li X, Liu Q, Xu J, et al
    UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  8. XI G, Hayes E, Lewis R, Ichi S, et al
    CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-kappaB pathway in multidrug-resistant glioblastoma cells in vitro.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format    


    August 2016
  9. HOU J, Deng Q, Zhou J, Zou J, et al
    CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
    Oncogene. 2016 Aug 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    July 2016
  10. BLANCHART A, Fernando R, Haring M, Assaife-Lopes N, et al
    Endogenous GABAA receptor activity suppresses glioma growth.
    Oncogene. 2016 Jul 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    June 2016
  11. CAI H, Liu X, Zheng J, Xue Y, et al
    Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  12. BANASAVADI-SIDDEGOWDA YK, Russell L, Frair E, Karkhanis VA, et al
    PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.
    Oncogene. 2016 Jun 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  13. HUANG MY, Xuan F, Liu W, Cui HJ, et al
    MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation.
    Oncogene. 2016 Jun 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  14. MONDAL B, Patil V, Shwetha SD, Sravani K, et al
    Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration.
    Oncogene. 2016 May 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  15. GHOOCHANI A, Schwarz MA, Yakubov E, Engelhorn T, et al
    MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  16. WEN J, Lee J, Malhotra A, Nahta R, et al
    WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma.
    Oncogene. 2016 Apr 18. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  17. SHI X, Wang Q, Gu J, Xuan Z, et al
    SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  18. CAMPOS B, Olsen LR, Urup T, Poulsen HS, et al
    A comprehensive profile of recurrent glioblastoma.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  19. ELLERT-MIKLASZEWSKA A, Wisniewski P, Kijewska M, Gajdanowicz P, et al
    Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  20. ZHANG L, Zhang W, Li Y, Alvarez A, et al
    SHP-2-upregulated ZEB1 is important for PDGFRalpha-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    February 2016
  21. LOPEZ-BERTONI H, Lal B, Michelson N, Guerrero-Cazares H, et al
    Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
    Oncogene. 2016 Feb 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  22. CHUA CY, Liu Y, Granberg KJ, Hu L, et al
    IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
    Oncogene. 2016;35:738-47.
    PubMed     Text format     Abstract available


  23. PEIXOTO P, Blomme A, Costanza B, Ronca R, et al
    HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies.
    Oncogene. 2016 Feb 8. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    January 2016
  24. DEY A, Robitaille M, Remke M, Maier C, et al
    YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.
    Oncogene. 2016 Jan 4. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    November 2015
  25. AUVERGNE R, Wu C, Connell A, Au S, et al
    PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.
    Oncogene. 2015 Nov 30. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  26. SCHULZE M, Fedorchenko O, Zink TG, Knobbe-Thomsen CB, et al
    Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.
    Oncogene. 2015 Nov 9. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    September 2015
  27. SARTORIUS CA, Hanna CT, Gril B, Cruz H, et al
    Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism.
    Oncogene. 2015 Sep 28. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  28. TREPS L, Edmond S, Harford-Wright E, Galan-Moya EM, et al
    Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma.
    Oncogene. 2015 Sep 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  29. GEREZ J, Tedesco L, Bonfiglio JJ, Fuertes M, et al
    RSUME inhibits VHL and regulates its tumor suppressor function.
    Oncogene. 2015;34:4855-66.
    PubMed     Text format     Abstract available


    August 2015
  30. PEREZ JG, Tran NL, Rosenblum MG, Schneider CS, et al
    The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.
    Oncogene. 2015 Aug 24. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  31. YEN SY, Chen SR, Hsieh J, Li YS, et al
    Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion.
    Oncogene. 2015 Aug 10. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    July 2015
  32. LOPEZ-BERTONI H, Lal B, Li A, Caplan M, et al
    DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2.
    Oncogene. 2015;34:3994-4004.
    PubMed     Text format     Abstract available


  33. SIN WC, Aftab Q, Bechberger JF, Leung JH, et al
    Astrocytes promote glioma invasion via the gap junction protein connexin43.
    Oncogene. 2015 Jul 13. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  34. GARCIA I, Crowther AJ, Gama V, Miller CR, et al
    Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.
    Oncogene. 2015;34:3881.
    PubMed     Text format    


    June 2015
  35. AHN BY, Saldanha-Gama RF, Rahn JJ, Hao X, et al
    Glioma invasion mediated by the p75 neurotrophin receptor (p75/CD271) requires regulated interaction with PDLIM1.
    Oncogene. 2015 Jun 29. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    May 2015
  36. FRIEDMANN-MORVINSKI D, Bhargava V, Gupta S, Verma IM, et al
    Identification of therapeutic targets for glioblastoma by network analysis.
    Oncogene. 2015 May 11. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    April 2015
  37. PARDO OE
    Meningioma dissemination and growth: a role for microRNAs.
    Oncogene. 2015;34:1743-4.
    PubMed     Text format    


    March 2015
  38. XI G, Hayes E, Lewis R, Ichi S, et al
    CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-kappaB pathway in multidrug-resistant glioblastoma cells in vitro.
    Oncogene. 2015 Mar 30. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  39. SLEIRE L, Skeie BS, Netland IA, Forde HE, et al
    Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc, leading to glutathione depletion.
    Oncogene. 2015 Mar 23. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  40. VASSALLO I, Zinn P, Lai M, Rajakannu P, et al
    WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
    Oncogene. 2015 Mar 16. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    February 2015
  41. TUOMINEN I, Heliovaara E, Raitila A, Rautiainen MR, et al
    AIP inactivation leads to pituitary tumorigenesis through defective Galphai-cAMP signaling.
    Oncogene. 2015;34:1174-84.
    PubMed     Text format     Abstract available


  42. GILLAM MP, Nimbalkar D, Sun L, Christov K, et al
    MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.
    Oncogene. 2015;34:932-8.
    PubMed     Text format     Abstract available


  43. XING F, Sharma S, Liu Y, Mo YY, et al
    miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-alpha
    Oncogene. 2015 Feb 9. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


  44. GREENALL SA, Donoghue JF, Van Sinderen M, Dubljevic V, et al
    EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implications.
    Oncogene. 2015 Feb 9. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


    January 2015
  45. LEWIS CA, Brault C, Peck B, Bensaad K, et al
    SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme.
    Oncogene. 2015 Jan 26. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


  46. QUE T, Song Y, Liu Z, Zheng S, et al
    Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1.
    Oncogene. 2015;0.
    PubMed     Text format     Abstract available


  47. LECOINTRE C, Desrues L, Joubert JE, Perzo N, et al
    Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma.
    Oncogene. 2015 Jan 19. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


    December 2014
  48. LINDSEY JC, Kawauchi D, Schwalbe EC, Solecki DJ, et al
    Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance.
    Oncogene. 2014 Dec 22. doi: 10.1038/onc.2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: